Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women

Introduction In 2016, WHO estimated there were roughly 374 million new infections among adults of the following four curable sexually transmitted infections (STIs): chlamydia (caused by Chlamydia trachomatis (CT)), gonorrhoea (Neisseria gonorrhoeae (NG)), syphilis (Treponema pallidum) and trichomoni...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos F Cáceres, James Kiarie, Rosanna W Peeling, Magnus Unemo, Karel Blondeel, Igor Toskin, Amina Hançali, Silver Vargas, Carlos Caceres, Christian S Alvarez, Ranmini Kularatne, Ting-Ting Jiang, Soe Soe Thwin, Maddalena Cordioli, Lorenzo Gios, Massimo Mirandola, Antonella Zorzi, Christopher Barbara, Valeska Padovese, Hicham Oumzi, Rosanna Peeling, Ronald Ballard, Elsy Camey, Ron Ballard, Christian S. Alvarez, Elsy Camey de Astorga
Format: Article
Language:English
Published: BMJ Publishing Group 2024-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/6/e073565.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850097768990769152
author Carlos F Cáceres
James Kiarie
Rosanna W Peeling
Magnus Unemo
Karel Blondeel
Igor Toskin
Amina Hançali
Silver Vargas
Carlos Caceres
Christian S Alvarez
Ranmini Kularatne
Ting-Ting Jiang
Soe Soe Thwin
Maddalena Cordioli
Lorenzo Gios
Massimo Mirandola
Antonella Zorzi
Christopher Barbara
Valeska Padovese
Hicham Oumzi
Rosanna Peeling
Ronald Ballard
Elsy Camey
Ron Ballard
Christian S. Alvarez
Elsy Camey de Astorga
author_facet Carlos F Cáceres
James Kiarie
Rosanna W Peeling
Magnus Unemo
Karel Blondeel
Igor Toskin
Amina Hançali
Silver Vargas
Carlos Caceres
Christian S Alvarez
Ranmini Kularatne
Ting-Ting Jiang
Soe Soe Thwin
Maddalena Cordioli
Lorenzo Gios
Massimo Mirandola
Antonella Zorzi
Christopher Barbara
Valeska Padovese
Hicham Oumzi
Rosanna Peeling
Ronald Ballard
Elsy Camey
Ron Ballard
Christian S. Alvarez
Elsy Camey de Astorga
collection DOAJ
description Introduction In 2016, WHO estimated there were roughly 374 million new infections among adults of the following four curable sexually transmitted infections (STIs): chlamydia (caused by Chlamydia trachomatis (CT)), gonorrhoea (Neisseria gonorrhoeae (NG)), syphilis (Treponema pallidum) and trichomoniasis (Trichomonas vaginalis (TV)). Accurate point-of-care tests (POCTs) for screening of genital and extragenital CT, NG and TV infections are of great value and have been developed during recent decade. Several tests are commercially available and have shown encouraging performance compared with ‘gold-standard’ reference tests in laboratory-based studies. However, there is limited data on their clinical performance, including at the POC. Key populations, such as men who have sex with men (MSM), are at higher risk of these STIs at genital and extragenital sites and these STIs are often asymptomatic, especially in extragenital sites and in women. We will conduct a clinical-based evaluation to assess the performance characteristics and acceptability to end-users of molecular-based diagnostic technology for POC/near patient use of the Xpert CT/NG (Cepheid, Sunnyvale, California, USA) test for screening of genital, anorectal and pharyngeal CT and NG infections in MSM and the Xpert CT/NG and Xpert TV (Cepheid, Sunnyvale, California, USA) for screening of genital CT, NG and TV among women at risk for these STIs compared with gold-standard reference nucleic acid amplification tests. This master protocol outlines the overall research approach that will be used in seven countries.Method and analyses Consecutive MSM and women at risk presenting at the clinical sites in high, and low- and middle-income countries will be enrolled. The POCTs to be evaluated are Xpert CT/NG and Xpert TV. All procedures will be carried out by trained healthcare staff and tests performed in strict accordance with the manufacturer’s instructions. The sensitivity, specificity, positive and negative predictive values for each POCT will be calculated. The study is ongoing with recruitment expected to be completed in all countries by mid-2022 to late-2022.Ethics and dissemination Prior to enrolment, this core protocol was independently peer-reviewed and approved by the research project review panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research and by the WHO Ethics Review Committee (ERC). The core protocol has been slightly adapted accordingly to individual countries and adaptations approved by both RP2 and ERC, as well as all relevant institutional review boards at each participating site. Results will be disseminated through peer-reviewed journals and presented at relevant national/international conferences.
format Article
id doaj-art-118a4df704ce4ac59aeb4c53232be929
institution DOAJ
issn 2044-6055
language English
publishDate 2024-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-118a4df704ce4ac59aeb4c53232be9292025-08-20T02:40:52ZengBMJ Publishing GroupBMJ Open2044-60552024-06-0114610.1136/bmjopen-2023-073565Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women Carlos F Cáceres0James Kiarie1Rosanna W Peeling2Magnus Unemo3Karel Blondeel4Igor Toskin5Amina Hançali6Silver Vargas7Carlos CaceresChristian S Alvarez8Ranmini Kularatne9Ting-Ting Jiang10Soe Soe Thwin11Maddalena Cordioli12Lorenzo Gios13Massimo Mirandola14Antonella Zorzi15Christopher Barbara16Valeska Padovese17Hicham Oumzi18Rosanna PeelingRonald BallardElsy Camey19Ron Ballard20Christian S. AlvarezElsy Camey de Astorga10 Unit of Health, Sexuality and Human Development, Universidad Peruana Cayetano Heredia, Lima, PeruDepartment of Sexual and Reproductive Health and Research, including UNDP/ UNFPA/UNICEF/WHO/ World Bank Special programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland13 Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UKWorld Health Organization Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden19 Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium18 Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland6 Ministry of Health, National Institute of Hygiene, Rabat, Morocco11 Laboratory of Sexual Health, Center for Interdisciplinary Research on Sexuality, AIDS and Society, Universidad Peruana Cayetano Heredia, Lima, Peru12 Sida y Sociedad ONG (SISO), Escuintla, Guatemala8 National Institute for Communicable Diseases, Johannesburg, South Africa9 Institute of Dermatology/Hospital for Skin Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China20 Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland2 Infectious Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy1 WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy1 WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy1 WHO Collaborating Centre for Sexual Health and Vulnerable Populations - Epidemiology Unit - Division of Infectious Diseases, Department of Medicine, Verona University Hospital, Verona, Italy4 Pathology Department, Mater Dei Hospital, Msida, Malta, Malta4 Genitourinary Department, Mater Dei Hospital, Msida, Malta7 National Institute of Hygiene, Ministry of Health, Rabat, Morocco12 Sida y Sociedad ONG (SISO), Escuintla, Guatemala17 Consultant to WHO Headquarters - Geneva, The Villages, Florida, USAIntroduction In 2016, WHO estimated there were roughly 374 million new infections among adults of the following four curable sexually transmitted infections (STIs): chlamydia (caused by Chlamydia trachomatis (CT)), gonorrhoea (Neisseria gonorrhoeae (NG)), syphilis (Treponema pallidum) and trichomoniasis (Trichomonas vaginalis (TV)). Accurate point-of-care tests (POCTs) for screening of genital and extragenital CT, NG and TV infections are of great value and have been developed during recent decade. Several tests are commercially available and have shown encouraging performance compared with ‘gold-standard’ reference tests in laboratory-based studies. However, there is limited data on their clinical performance, including at the POC. Key populations, such as men who have sex with men (MSM), are at higher risk of these STIs at genital and extragenital sites and these STIs are often asymptomatic, especially in extragenital sites and in women. We will conduct a clinical-based evaluation to assess the performance characteristics and acceptability to end-users of molecular-based diagnostic technology for POC/near patient use of the Xpert CT/NG (Cepheid, Sunnyvale, California, USA) test for screening of genital, anorectal and pharyngeal CT and NG infections in MSM and the Xpert CT/NG and Xpert TV (Cepheid, Sunnyvale, California, USA) for screening of genital CT, NG and TV among women at risk for these STIs compared with gold-standard reference nucleic acid amplification tests. This master protocol outlines the overall research approach that will be used in seven countries.Method and analyses Consecutive MSM and women at risk presenting at the clinical sites in high, and low- and middle-income countries will be enrolled. The POCTs to be evaluated are Xpert CT/NG and Xpert TV. All procedures will be carried out by trained healthcare staff and tests performed in strict accordance with the manufacturer’s instructions. The sensitivity, specificity, positive and negative predictive values for each POCT will be calculated. The study is ongoing with recruitment expected to be completed in all countries by mid-2022 to late-2022.Ethics and dissemination Prior to enrolment, this core protocol was independently peer-reviewed and approved by the research project review panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research and by the WHO Ethics Review Committee (ERC). The core protocol has been slightly adapted accordingly to individual countries and adaptations approved by both RP2 and ERC, as well as all relevant institutional review boards at each participating site. Results will be disseminated through peer-reviewed journals and presented at relevant national/international conferences.https://bmjopen.bmj.com/content/14/6/e073565.full
spellingShingle Carlos F Cáceres
James Kiarie
Rosanna W Peeling
Magnus Unemo
Karel Blondeel
Igor Toskin
Amina Hançali
Silver Vargas
Carlos Caceres
Christian S Alvarez
Ranmini Kularatne
Ting-Ting Jiang
Soe Soe Thwin
Maddalena Cordioli
Lorenzo Gios
Massimo Mirandola
Antonella Zorzi
Christopher Barbara
Valeska Padovese
Hicham Oumzi
Rosanna Peeling
Ronald Ballard
Elsy Camey
Ron Ballard
Christian S. Alvarez
Elsy Camey de Astorga
Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
BMJ Open
title Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
title_full Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
title_fullStr Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
title_full_unstemmed Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
title_short Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women
title_sort standardised protocol for a prospective international multicentre clinical based evaluation of point of care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial gonococcal and trichomonas vaginalis infections in at risk women
url https://bmjopen.bmj.com/content/14/6/e073565.full
work_keys_str_mv AT standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT carlosfcaceres standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT jameskiarie standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT rosannawpeeling standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT magnusunemo standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT karelblondeel standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT igortoskin standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT aminahancali standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT silvervargas standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT carloscaceres standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT christiansalvarez standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT ranminikularatne standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT tingtingjiang standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT soesoethwin standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT maddalenacordioli standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT lorenzogios standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT massimomirandola standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT antonellazorzi standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT christopherbarbara standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT valeskapadovese standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT hichamoumzi standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT rosannapeeling standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT ronaldballard standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT elsycamey standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT ronballard standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT christiansalvarez standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas
AT elsycameydeastorga standardisedprotocolforaprospectiveinternationalmulticentreclinicalbasedevaluationofpointofcaretestsforthescreeningofgenitalandextragenitalchlamydialandgonococcalinfectionsinmenwhohavesexwithmenandforthescreeningofgenitalchlamydialgonococcalandtrichomonas